Friday, October 26, 2018

Investorideas.com - Investor Ideas Adds New #Nasdaq IPOs in #Biotech (Nasdaq: $ALLO, $EQ, $GH, $KOD, $PRNB, $YMAB) & Newly Listed #CSE Stocks

Investor Ideas Adds New #Nasdaq IPOs in #Biotech (Nasdaq: $ALLO, $EQ, $GH, $KOD, $PRNB, $YMAB) & Newly Listed #CSE Stocks

CSE-Listed Stocks in #Mining, #Energy and #Nanotech (CSE: $CRES, $DLRY, $KAL, $SENS, $SONA)

Point Roberts, WA and Delta, BC - October 26, 2018 (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource announces this week’s additions to its global stock directories in biotech, mining, energy and nanotech.

Investorideas.com is a go- to destination for retail investors and tracks companies in high-profile trading sectors and makes ongoing additions to its stock directories for its followers and members . (https://www.investorideas.com/membership/)

New biotech companies are all recent Nasdaq IPO's and include biotech, oncology, biopharma and life sciences companies providing treatments for cancer, autoimmune and ophthalmic diseases.

The latest mining companies are all CSE-Listed and operate in Canada, while the newest energy company (also CSE-Listed), is a leading solutions provider to various sectors including the oil and gas industry.

Finally, the newest nanotech company Sona Nanotech Inc. (CSE: SONA), also crosses over into the biotech (life sciences) sector with their rod-shaped gold nanoparticles which are used in multiplex diagnostic testing platforms.

New Biotech Companies:

ALLOGENE THERAPEUTICS, INC. (NasdaqGS: ALLO) with headquarters in South San Francisco, is a clinical stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T-cell (AlloCAR T™) therapies for cancer.

EQUILLIUM, INC (NasdaqGM: EQ) is a biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders with high unmet medical need. Equillium's initial product candidate, EQ001 (itolizumab), is a clinical-stage, first-in-class monocolonal antibody that selectively targets the novel immune checkpoint receptor CD6 and is designed to modulate T cells that drive immuno-inflammation. Itolizumab is a clinically-validated therapeutic with a favorable safety and tolerability profile. Equillium plans to advance EQ001 into clinical development in multiple indications of high unmet medical need and believes EQ001 has the potential to be a best-in-class disease modifying therapeutic.

GUARDANT HEALTH, INC. (NasdaqGS: GH) is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Its Guardant Health Oncology Platform is designed to leverage its capabilities in technology, clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. In pursuit of its goal to manage cancer across all stages of the disease, Guardant Health has launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its LUNAR development programs for recurrence and early detection. Since its launch in 2014, Guardant360 has been used by more than 5,000 oncologists, over 40 biopharmaceutical companies and all 27 of the National Comprehensive Cancer Network centers.

KODIAK SCIENCES INC. (NasdaqGM: KOD) is a clinical stage company developing innovative therapeutics to treat high prevalence ophthalmic diseases. We aspire to global leadership in ophthalmology through internal focus and by aggregating top talent, technologies, discoveries and ideas. Our Antibody Biopolymer Conjugate, or ABC Platform™, merges the fields of antibody-based and chemistry-based therapies and is at the core of Kodiak's discovery engine. In addition to its lead product candidate, KSI-301, a potential best in class molecule for age-related macular degeneration and diabetic retinopathy, Kodiak has leveraged its ABC Platform™ to build a pipeline of product candidates in various stages of development including KSI-501, a dual inhibitor ABC for the treatment of neovascular retinal diseases such as wet AMD and diabetic retinopathy. Kodiak is based in Palo Alto, CA.

PRINCIPIA BIOPHARMA INC. (NasdaqGS:PRNB) is a clinical-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with significant unmet medical needs in immunology and oncology. Principia's proprietary Tailored Covalency® platform enables Principia to design and develop reversible and irreversible covalent, small molecule inhibitors with potencies and selectivities that have the potential to rival those of injectable biologics, yet maintain the convenience of a pill. PRN1008, a reversible covalent BTK inhibitor, is being evaluated in a Phase 2 clinical trial in patients with pemphigus, an orphan autoimmune disease, and in a Phase 2 clinical trial in patients with ITP, a rare hematological disease. PRN2246, a covalent BTK inhibitor which crosses the blood-brain barrier, has completed a Phase 1 clinical trial in healthy volunteers, and has been partnered with Sanofi for development in multiple sclerosis and, potentially, for other diseases of the CNS. PRN1371, a covalent inhibitor of Fibroblast Growth Factor Receptor (FGFR), is being evaluated in a Phase 1 trial in patients with solid tumors.

Y-mAbs THERAPEUTICS, INC. (NasdaqGS: YMAB) is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. The Company has a broad and advanced product pipeline, including two pivotal-stage product candidates-naxitamab and omburtamab-which target tumors that express GD2 and B7-H3, respectively.

New Mining Companies:

Crest Resources Inc. (CSE: CRES) is engaged in the business of mineral exploration and the acquisition of mineral property assets in Canada. Its objective is to locate and develop economic precious and base metal properties of merit and to conduct its exploration program on the Red Metal Ridge Property. The Red Metal Ridge Property is comprised of six contiguous mineral titles covering an area of 1381.50 hectares, located 74 kilometres northwest of the town of Campbell River and 12 kilometres southwest of the town of Sayward on Vancouver Island, British Columbia, Canada.

Delrey Metals Corp. (CSE:DLRY) is an exploration stage mineral resources company whose principal business activities include acquiring, exploring and evaluating strategic energy mineral properties

Kal Minerals Corp. (CSE: KAL) is a Canadian junior mineral exploration company with a specific focus on properties in the New Westminster Mining Division of British Columbia, Canada. The Company's sole property, the Jack White Property, is comprised of four mineral tenures covering approximately 2,202 hectares approximately 13km northeast of Boston Bar, British Columbia.

New Energy Companies:

Sensor Technologies Inc. (CSE:SENS) - formerly Mooncor Oil and Gas Corp - is a leading solutions provider to various sectors including the oil and gas industry. With non-intrusive technologies including fiber-optic sensors and electric field mapping EFM systems. Sensor Technologies Corp is able to accurately measure changes that could negatively impact our client's operations. SENS F.O. sensors are a non-invasive tool for monitoring pipeline defects in real time. consist of non-intrusive sensors, monitor & software. SENS's EFM monitoring of isolated pit formation & growth using a non-permanent modular design based on electrical resistance measurements, monitoring locations may be placed hundreds of feet away from the sensors. Software operates in continuous or scheduled reporting modes. SENS's latest tech, is its leak detection system, for use in application such as Pipe sections at remote facilities Monitoring of Military, Scientific installations for corrosive liquids in harsh environments , in tank farms, pipe sections, Water leak detection in data centers & buildings.

New Nanotech Companies:

Sona Nanotech Inc. (CSE: SONA) is a nanotechnology life sciences firm that has developed two proprietary methods for the manufacture of rod-shaped gold nanoparticles. The principal business carried out and intended to be continued by Sona is the development and application of its proprietary technology for use in multiplex diagnostic testing platforms that will improve performance over existing tests in the market. Sona's gold nanorod particles are CTAB (cetyltrimethylammonium) free, eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. It is expected that Sona's gold nanotechnologies may be adapted for use in applications, as a safe and effective delivery system for multiple medical treatments, pending the approval of various regulatory boards including Health Canada and the FDA.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer and disclosure info: https://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

To sponsor one of our podcasts or columns or be a guest call us today!

Contact Investorideas.com

800-665-0411

Friday, October 12, 2018

Investorideas.com - Investor Ideas adds Nasdaq #Biotech #IPOs and CSE #Mining IPO Stocks to Directories (NASDAQ: $ADIL), (NASDAQ: $ALLK) (NASDAQ: $AQST), (CSE: $ZX.C)

Investor Ideas adds Nasdaq #Biotech #IPOs and CSE #Mining IPO Stocks to Directories (NASDAQ: $ADIL), (NASDAQ: $ALLK) (NASDAQ: $AQST), (CSE: $ZX.C)

Point Roberts, WA and Delta, BC - September 21, 2018 (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource announces this week's additions to its global stock directories in biotech and mining.

The newest companies in biotech are all Nasdaq IPO listings from within the past few weeks and include pharmaceutical, medical device and biopharma companies looking to treat a variety of diseases and unmet medical conditions/needs.

The latest mining company is a recent CSE listing that is exploring and developing properties in Quebec and BC, Canada.

New Biotech Companies

ADIAL PHARMACEUTICALS, INC. (NasdaqCM: ADIL) is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions. The Company's lead investigational new drug candidate, AD04, is a genetically targeted therapeutic agent for the treatment of alcohol use disorder (AUD). A Phase 2b clinical trial of AD04 for the treatment of AUD showed promising results in reducing frequency of drinking, quantity of drinking and heavy drinking (all with statistical significance), and no overt safety concerns (there were no statistically significant serious adverse events reported). The Company plans to commence a Phase 3 clinical trial using AD04 for the potential treatment of AUD in subjects with certain target genotypes, which are to be identified using the Company's proprietary companion diagnostic genetic test. AD04 is also believed to have the potential to treat other addictive disorders such as opioid use disorder, gambling, and obesity.

ALLAKOS INC. (NasdaqGS:ALLK) is a clinical stage company developing antibodies that target immunomodulatory receptors present on immune effector cells involved in allergic, inflammatory, and proliferative diseases. The Company's lead antibody, AK002, targets Siglec-8, an inhibitory receptor selectively expressed on human mast cells and eosinophils. Inappropriately activated eosinophils and mast cells have been identified as key drivers in a number of severe diseases affecting the gastrointestinal tract, eyes, skin, lungs and other organs. AK002 has completed two Phase 1 trials, one in healthy volunteers and a single ascending dose trial in patients with indolent systemic mastocytosis. AK002 demonstrated pharmacodynamic activity in both trials and in the trial involving patients with indolent systemic mastocytosis, patients reported improvements in their symptoms. AK002 is being tested in a Phase 2 trial for the treatment of eosinophilic gastritis and eosinophilic gastroenteritis. In addition, Allakos is conducting multiple-dose trials with AK002 in chronic urticaria, indolent systemic mastocytosis, and severe allergic conjunctivitis.

AQUESTIVE THERAPEUTICS, INC. (NasdaqGM: AQST) is a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to address unmet medical needs. Aquestive Therapeutics has a late-stage proprietary product pipeline focused on the treatment of CNS diseases, and is working to advance orally-administered complex molecules that it believes can be alternatives to invasively-administered standard of care therapies. As the leader in developing and delivering drugs via its PharmFilm® technology, Aquestive Therapeutics also collaborates with pharmaceutical partners to bring new molecules to market in differentiated and highly-marketable dosage forms.

CONSTELLATION PHARMACEUTICALS INC (NasdaqGS:CNST) is a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance. With a decade of experience in the field, the Company has a deep understanding of how epigenetic regulators modulate gene expression in cancer cells and in the tumor and immune microenvironment. Constellation is translating these insights to advance the Company's two lead clinical programs, the EZH2 inhibitor CPI-1205 for metastatic castration-resistant prostate cancer and solid tumors and the BET inhibitor CPI-0610 for myelofibrosis, and to explore other novel targets for which cancer epigenetics may enhance outcomes over currently available treatment options.

CRINETICS PHARMACEUTICALS, INC. (NasdaqGS:CRNX) is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly, an orphan disease affecting more than 25,000 people in the United States. The company is also developing other oral nonpeptide somatostatin agonists for hyperinsulinism and neuroendocrine tumors, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. Crinetics was founded by a team of scientists with a track record of endocrine drug discovery and development.

ESTABLISHMENT LABS HOLDINGS INC. (NasdaqCM:ESTA) is a global medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform. Motiva Implants® are produced at two FDA compliant state-of-the-art facilities in Costa Rica and currently sold in over 60 countries through exclusive distributors or the Company's direct salesforce. In March 2018, Establishment Labs received approval for an investigational device exemption (IDE) from the FDA and initiated the Motiva Implant® clinical trial in the United States in April 2018. In addition to Motiva Implants®, Establishment Labs' product and technologies portfolio includes the Divina® 3D Simulation System, Puregraft and MotivaImage® Centers.

LIQUIDIA TECHNOLOGIES INC (NasdaqCM: LQDA) is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT® technology to transform the lives of patients. PRINT® is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. Currently, Liquidia is focused on the development of two product candidates for which it holds worldwide commercial rights: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia's lead product candidate, LIQ861, currently being evaluated in a Phase 3 clinical trial (INSPIRE), is designed to improve the therapeutic profile of treprostinil by enhancing deep-lung delivery and achieving higher dose levels than current inhaled therapies by using a convenient, disposable dry powder inhaler. LIQ865, for which Liquidia has recently completed a U.S. Phase 1b clinical trial, is designed to deliver sustained-release particles of bupivacaine, a non-opioid anesthetic, to treat local post-operative pain for three to five days through a single administration. In addition to developing its own product candidates, Liquidia collaborates with leading pharmaceutical companies to develop their own product candidates across a wide range of therapeutic areas, molecule types and routes of administration, leveraging Liquidia's PRINT® technology.

PROVENTION BIO, INC (NasdaqCM:PRVB) is a clinical-stage biopharmaceutical company leveraging a transformational drug development strategy that is focused on the prevention or interception of immune-mediated disease. Our diverse portfolio was assembled with product candidates that have undergone clinical testing but may have been underdeveloped or deprioritized assets at other companies. Provention's mission is to in-license, transform and develop clinical-stage, or nearly clinical-stage, therapeutic candidates targeting the high morbidity, mortality and escalating costs of autoimmune and inflammatory diseases including: type 1 diabetes (T1D), Crohn's disease, ulcerative colitis, lupus, and certain life-threating viral diseases.

REPLIMUNE GROUP, INC. (NasdaqGS:REPL) headquartered in Woburn, MA, was founded in 2015 to develop the next generation of "oncolytic immunotherapies" for the treatment of cancer. Replimune is developing novel, proprietary therapeutics intended to improve the direct cancer-killing effects of selective virus replication and the potency of the immune response to the tumor antigens released. The Company's Immulytic™ platform is designed to maximize systemic immune activation, in particular to tumor neoantigens, through robust viral mediated immunogenic tumor cell killing and the delivery of optimal combinations of immune-activating proteins to the tumor and draining lymph nodes. The approach is expected to be highly synergistic with immune checkpoint blockade and other approaches to cancer treatment. Replimune intends to progress these therapies rapidly through clinical development in combination with other immuno-oncology products with complementary mechanisms of action

RUBIUS THERAPEUTICS, INC. (NasdaqGS:RUBY) is a biopharmaceutical company pioneering the development of a new class of medicines called Red Cell Therapeutics™. The Company's proprietary RED PLATFORM™ was designed to genetically engineer and culture Red Cell Therapeutics™ that are selective, potent and ready-to-use cellular therapies for the potential treatment of several diseases across multiple therapeutic areas. Rubius' initial focus is to advance RCT™ product candidates for the treatment of rare diseases, cancer and autoimmune diseases by leveraging three distinct therapeutic modalities — cellular shielding, potent cell-cell interaction and tolerance induction

VACCINEX, INC. (NasdqGM: VCNX) is a clinical-stage immunotherapy company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders, with currently active clinical trials in Non-Small Cell Lung Cancer and Huntington's disease. Vaccinex is based in Rochester, New York.

New Mining Companies

Zenith Exploration Inc. (CSE:ZX) is a resource exploration issuer that acquires and explores mineral properties. Zenith's principal property is in Quebec and its secondary property is in BC. The Company intends to explore and develop these properties.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Investing Ideas

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

To sponsor one of our podcasts or columns or be a guest call us today!

Contact Investorideas.com

https://www.investorideas.com/About/Contact.asp

800-665-0411

Friday, September 21, 2018

Investorideas.com - Investor Ideas add new #Solar, #Cleantech, #Mining, #Blockchain, Tech, Water and Sports #Stocks to Global Directories

Investor Ideas add new #Solar, #Cleantech, #Mining, #Blockchain, Tech, Water and Sports #Stocks to Global Directories

New cleantech companies added this week are doing business in solar energy, energy infrastructure and energy efficiency.

The latest mining additions are companies exploring for gold and zinc respectively, while Cascadia Blockchain Group Corp. (CSE: CK) is the latest blockchain company and is also involved in the fintech sector. The newest tech company is involved in SAAS for cloud and enterprise networks.

Investor Ideas has also added new companies in water, technology and in the sports sector.

New Cleantech Companies:

AltaGas Ltd. (TSX: ALA.TO) is an energy infrastructure company with a focus on natural gas, power and regulated utilities. AltaGas creates value by growing and optimizing its energy infrastructure, including a focus on clean energy sources.

Just Energy Group, Inc. (TSX:JE.TO; NYSE:JE) is a leading consumer company specializing in electricity and natural gas commodities, energy efficiency solutions, and renewable energy options. With offices located across the United States, Canada, the United Kingdom, Germany, Ireland and Japan, Just Energy serves approximately 1.7 million residential and commercial customers providing homes and businesses with a broad range of energy solutions that deliver comfort, convenience and control. Just Energy Group Inc. is the parent company of Amigo Energy, Green Star Energy, Hudson Energy, EdgePower Inc., Tara Energy and terrapas

Pinnacle Renewable Holdings Inc. (TSX: PL.TO) is a rapidly growing industrial wood pellet manufacturer and distributor and the third largest producer in the world. The Company produces sustainable fuel for renewable electricity generation in the form of industrial wood pellets. This fuel is used by large-scale thermal power generators as a greener alternative to produce reliable baseload renewable power. Pinnacle is a trusted supplier to its customers, who require reliable, high quality fuel supply to maximize utilization of their facilities. Pinnacle takes pride in its industry leading safety practices. The Company operates seven industrial wood pellet production facilities in western Canada, a port terminal in Prince Rupert, B.C., and currently has a new production facility under construction in Smithers, B.C. Pinnacle has entered into long-term take-or-pay contracts with utilities in the U.K., Europe and Asia that represent 106% of its production capacity through 2021 and 98% of its production capacity through 2026.

Daqo New Energy Corporation (NYSE:DQ) is a leading manufacturer of high-purity polysilicon for the global solar PV industry. Founded in 2008, the Company is one of the world's lowest cost producers of high-purity polysilicon. Daqo's highly-efficient and technically advanced manufacturing facility in Xinjiang China currently has annual polysilicon production capacity of 18,000 metric tons, and the Company is undergoing capacity expansion to reach annual polysilicon production capacity of 30,000 metric tons by the end of 2018.

Enphase Energy, Inc. (NasdaqGM: ENPH) a global energy technology company, delivers smart, easy-to-use solutions that connect solar generation, storage and management on one intelligent platform. The Company revolutionized solar with its microinverter technology and produces the world's only truly integrated solar plus storage solution. Enphase has shipped over 17 million microinverters, and more than 790,000 Enphase systems have been deployed in over 120 countries.

LONGi Green Energy Technology Co., Ltd. (Shanghai:601012.SS) always adhere to single crystal technology, bearing in mind the responsibility of improving human production and life, and providing sustainable energy for sustainable development. LONGimanufactures and sells single crystal silicon products worldwide. It offers single crystal silicon rod and silicon slice. The company was formerly known as Xi'an LONGI Silicon Materials Corp. and changed its name to LONGi Green Energy Technology Co Ltd in January 2017.

REC Silicon ASA (Oslo: REC.OL) is a global leader in silane-based, high-purity silicon materials. REC Silicon ASA is a leading producer of advanced silicon materials, supplying high-purity polysilicon and silicon gases to the solar and electronics industries worldwide.

SolarEdge Technologies, Inc. (NasdaqGS:SEDG) is a global leader in smart energy technology. By leveraging world-class engineering capabilities and with a relentless focus on innovation, SolarEdge creates smart energy solutions that power our lives and drive future progress. SolarEdge developed an intelligent inverter solution that changed the way power is harvested and managed in photovoltaic (PV) systems. The SolarEdge DC optimized inverter seeks to maximize power generation while lowering the cost of energy produced by the PV system. Continuing to advance smart energy, SolarEdge addresses a broad range of energy market segments through its PV, storage, EV charging, UPS, and grid services solutions.

Sunrun Inc. (NasdaqGS:RUN) is the nation's leading residential solar, storage and energy services company. With a mission to create a planet run by the sun, Sunrun has led the industry since 2007 with its solar-as-a-service model, which provides clean energy to households with little to no upfront cost and at a saving compared to traditional electricity. The company designs, installs, finances, insures, monitors and maintains the systems, while families receive predictable pricing for 20 years or more. The company also offers a home solar battery service, Sunrun Brightbox, that manages household solar energy, storage and utility power with smart inverter technology.

Cleantech and Climate Change Podcast - talking to thought leaders and management of publicly traded companies about today's problems and solutions for the future.

Hear a recent edition:

Cleantech and Climate Change Podcast - Investorideas.com Talks to Paul Hessburg, @PaulHessburg Research Landscape Ecologist about Recent Megafires and Solutions to Manage and Prevent Them

https://www.investorideas.com/Audio/Podcasts/2018/090418-Cleantech-PaulHessburg.mp3

Cleantech and Climate Change Podcast - Paul Hessburg, Research Landscape Ecologist talks about Recent Megafires and Solutions to Manage and Prevent Them

The Investorideas.com podcasts are syndicated on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music, plus many other sites.

Visit the Podcast page at Investorideas.com: https://www.investorideas.com/Audio/

https://www.investorideas.com/About/Contact.asp

New Mining Companies

Ubique Minerals (CSE:UBQ) Minerals is a zinc exploration company based in Toronto, Ontario with the mandate to acquire and explore properties that have a high potential of producing economic mineral deposits. Ubique is currently focused on further exploring and developing it's Daniel's Harbour and Buchans Wileys zinc properties strategically situated in Newfoundland, Canada.

Coolgardie Minerals (ASX:CM1.AX) is an imminent gold producer and explorer with over 549km2 of tenements in the proven gold-producing districts near Coolgardie, Western Australia, surrounding the Bullabulling Gold Project. Coolgardie Minerals has secured a large, high-quality ground position (the Bullabulling Project) made up of the Geko Gold Project and five other advanced prospects: First Find, Endeavour, Bungarra, Sunchaser-Reservoir and Ubini. These prospects are along the Bullabulling “shear zone” in the Kalgoorlie Terrane, with access to a highly trained local workforce and excellent regional infrastructure. Coolgardie Minerals plans to expand its exploration and development footprint while striving to achieve its strategic plan of being a 100,000oz gold producer within three years via organic growth and merger and acquisitions.

New Blockchain Companies

Cascadia Blockchain Group Corp. (CSE: CK) is an early stage blockchain technology company. Under the Fintech division, the Company engages in developing and commercialization of trading platform technology for selected blockchain based digital assets. Under the Blockchain Lab division, the Company actively develops blockchain technology enterprise solutions and provides related services for various industry sectors.

CRYPTOCORNER: Investorideas.com, a leader in crypto and blockchain investing news reports on what's driving the cryptocurrency markets with today's edition of Crypto Corner, now available in podcast.

Visit the CryptoCorner page at https://www.investorideas.com/crypto-corner/

The CryptoCorner is also released as a podcast https://www.investorideas.com/Audio/

To sponsor our daily podcast for the month or to be an expert guest please contact us!

New Tech Companies

Martello Technologies Group (TSX:MTLO.V) is a global leader in technology that manages the performance of real-time communications (VoIP, video, streaming) on cloud and enterprise networks. Our powerfully simple SD-WAN and SaaS solutions transform our customer's networks giving them confidence in the performance of real-time services on their cloud and enterprise networks.

New Water Companies

Rainmaker Worldwide Inc. (OTC:RAKR) is headquartered in Peterborough, Canada, with an innovation and manufacturing center in Rotterdam, Netherlands. Our patented water technology provides economical drinking water at scale wherever it's needed. Rainmaker builds two types of energy-efficient, fresh water-producing technologies: Air-to-Water, which harvests fresh water from the air and Water-to-Water, which transforms seawater or polluted water into drinking water. Our technology is both wind and solar powered, is deployable anywhere, and leaves no carbon traces. We also offer options for hybrid, grid and diesel-powered models. Our goal is to become a global leader in solving the worldwide water crisis. Simply put, we are creating safe, drinking water where little or none exists.

The new branded content, Play by Play covers what's new in sports and esports headlines plus recent news from publicly traded companies in the sector. It reaches out to sports fans and esports fans also investors in the sector.

Play by Play combines the best of daily of headlines in sports, esports and stocks for sports fans and investors that want to keep up to date in the sector and make informed decisions.

Visit the Play by Play page at https://www.investorideas.com/Sports/PlayByPlay.asp

https://www.investorideas.com/About/Contact.asp

New Sports Companies

ProSmart Enterprises Inc. (TSX:PROS.V) is the parent company of Sportgo – the global online network that connects sports fans, teams, and brands. ProSmart works with over 1,500 governing bodies in more than 100 countries and provides unprecedented access to the $1.3 trillion sports market through its proprietary marketplace engine. The Company is an emerging leader in sports content marketing through online tools, mobile apps and its disruptive marketing technology.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Investing Ideas

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

To sponsor one of our podcasts or columns or be a guest call us today!

Contact Investorideas.com

https://www.investorideas.com/About/Contact.asp

800-665-0411

Wednesday, September 19, 2018

Investorideas.com Newswire - #Mining Stock News: #SilverCrest (TSXV: $SIL.V; NYSE: $SILV) Expands Las Chispas Inferred Resource 4.3 Million Tonnes at 3.68 gpt Au and 347 gpt Ag, or 623 gpt AgEq for 87 Million Oz AgEq; Includes 1.6 Million Tonnes at 1,091 gpt AgEq for 56 Million Oz AgEq

Investorideas.com Newswire - #Mining Stock News: #SilverCrest (TSXV: $SIL.V; NYSE: $SILV) Expands Las Chispas Inferred Resource 4.3 Million Tonnes at 3.68 gpt Au and 347 gpt Ag, or 623 gpt AgEq for 87 Million Oz AgEq; Includes 1.6 Million Tonnes at 1,091 gpt AgEq for 56 Million Oz AgEq

#Mining Stock News: #SilverCrest (TSXV: $SIL.V; NYSE: $SILV) Expands Las Chispas Inferred Resource 4.3 Million Tonnes at 3.68 gpt Au and 347 gpt Ag, or 623 gpt AgEq for 87 Million Oz AgEq; Includes 1.6 Million Tonnes at 1,091 gpt AgEq for 56 Million Oz AgEq

Vancouver, British Columbia - September 19, 2018 (Investorideas.com Newswire) SilverCrest Metals Inc. (TSXV: SIL.V; NYSE American: SILV) ("SilverCrest" or the "Company") is pleased to announce the updated mineral resource estimation for the Las Chispas Property, located in Sonora, Mexico. Inferred Mineral Resources are estimated at 4.3 million tonnes grading 3.68 grams per tonne ("gpt") gold (or "Au") and 347 gpt silver (or "Ag"), or 623 gpt silver equivalent ("AgEq"; based on 75 (Ag):1 (Au) calculated using long-term silver and gold prices of US$18.50 per ounce silver and US$1,225 per ounce gold, with average metallurgical recoveries of 86.6% silver and 98.9% gold). The Inferred Resource Estimate contains 511,800 ounces gold and 48.3 million ounces silver, or 86.7 million ounces of AgEq, using a 150 gpt AgEq cut-off grade and minimum true vein width of approximately 1.5 metres. The combination of the Area 51 zone (Babicanora Vein) and adjacent Babicanora Norte Vein hosts a combined Inferred Resource of 1.6 million tonnes grading 6.97 gpt gold and 568 gpt silver, or 1,091 gpt AgEq containing 56.3 million ounces of AgEq. Of the 30 veins in the district, eight veins were used for the updated resource estimate: Babicanora (including Area 51 zone), Babicanora Norte, Granaditas, Las Chispas, Giovanni (including La Blanquita), William Tell, and Luigi. For comparative purposes, please refer to the technical maiden resource report titled "Technical Report and Mineral Resource Estimate for the Las Chispas Property, Sonora, Mexico"and effective February 12, 2018, as amended May 9, 2018 ("Maiden Resource Report").

Highlights of the Las Chispas Updated Resource (Sept. 2018) including comparison to the Maiden Resource Report (Feb. 2018):

38% increase in AgEq ounces from 62.8 to 86.7 million ounces AgEq;
26% increase in tonnes from 3.4 million to 4.3 million;
10% increase in AgEq grade from 568 gpt AgEq to 623 gpt AgEq;
75% increase in high-grade AgEq ounces greater than 1,000 gpt from 32.2 million (Area 51 zone) to 56.3 million (revised Area 51 and Babicanora Norte Vein);
66% increase in high-grade tonnes grading greater than 1,000 gpt from 967,000 tonnes to 1,606,000 tonnes;
Approximately 80% of the updated resource is in the Babicanora Area (3 veins) with 20% in the Las Chispas Area (5 veins).
Five epithermal veins in the maiden resource, eight epithermal veins in the updated resource. Total of 30 epithermal veins defined to date in district controlled by the Company; and
Discovery cost per AgEq ounce is estimated at US$0.30, inclusive of all property costs and G&A.

The increase in the Inferred Resource estimate is based on the following: (1) 24 additional drill holes in the Babicanora Vein, including Area 51 and Babicanora Footwall Vein, (2) expansion of Area 51 high-grade footprint from approximately 500 metres to 800 metres, (3) splitting the Babicanora Vein into three separate domains for statistical analysis and top-cutting, (4) discovery of the Babicanora Norte Vein with 40 drill holes, (5) discovery of the Granaditas Veins with 21 drill holes, (6) discovery of the Luigi Vein with 22 drill holes, and (7) expansion drilling of three additional drill holes into the Giovanni Vein.

N. Eric Fier, CPG, P.Eng and CEO, remarked, "The delivery of this updated resource estimate is another major milestone for SilverCrest as we continue to systematically expand high-grade mineralization in the Las Chispas district. In the spring of 2018, we started our Phase III drill program with a Q3 target of 75 to 85 million ounces silver equivalent at a grade of around 600 gpt AgEq. With the recent expansion and discovery of multiple high-grade veins and zones, this target has been exceeded with an updated Inferred Resource of 4.3 million tonnes grading 623 gpt AgEq for an estimated 86.7 million AgEq ounces. The most exciting aspects of this resource update are the high-grade resources identified in the Area 51 zone of the Babicanora Vein and the Babicanora Norte Vein. These two near surface adjacent zones cumulatively host 1.6 million tonnes grading 1,091 gpt AgEq for an estimated 56.3 million AgEq ounces which can conceptually be developed using the same underground infrastructure. The Company plans to continue exploration drilling with six to eight core drills operating up to Q1, 2019. A further resource update and a Preliminary Economic Assessment ("PEA") are planned for Q1, 2019. Congratulations to our team and supporters who have worked diligently to make several significant discoveries and milestones at Las Chispas over the last six months."

Notes:
* Area 51 zone only in maiden resource.
**Combination of Area 51 zone and adjacent Babicanora Norte Vein resource estimation.

(1) Conforms to NI 43-101, Companion Policy 43-101CP, and the Canadian Institution of Mining, Metallurgy and Petroleum ("CIM") Definition Standards on Mineral Resources and Mineral Reserves. Inferred Resources have been estimated from geological evidence and limited sampling and must be treated with a lower level of confidence than Measured and Indicated Resources.
(2) AgEq based on 75 (Ag):1 (Au), calculated using long-term silver and gold prices of U.S.$18.50 per ounce silver and U.S.$1,225 per ounce gold with average metallurgical recoveries of 86.6% silver and 98.9% gold.
(3) All numbers are rounded.
(4) Babicanora resource includes the Babicanora Vein with Area 51 zone and Babicanora Footwall Vein. Giovanni resource includes the Gio-mini and the La Blanquita veins.
(5) Resource estimations for the Las Chispas and William Tell veins and the historic dumps are unchanged from the Maiden Resource.
(6) Vein resource is reported using a 150 gpt AgEq cut-off grade and minimum 1.5 m true width (approximate), and surface stockpile resource is reported using a 100 gpt AgEq cut-off.

The mineral resource estimate is based on the Company's phase I, II, and III exploration programs from April 2016 to September 13, 2018 and is classified as an Inferred Mineral Resource. The effective date for the Updated Inferred Resource Estimate is September 13, 2018. Depending on the vein, drill sections were spaced 25 to 75 metres along strike, with intercepts on each section averaging 50 metres apart down dip. The most significant component of the data, collected and validated by SilverCrest between April 2018 and September 2018 (Phase III), are results from an additional 126 drill holes (38,635 metres). Since the startup of the Phase I exploration program in 2016, a total of 306 drill holes (83,230 metres), 8,984 (7,212 metres) underground channel samples, and 2,895 dump samples have been completed and analyzed which comprise the database up to September 13, 2018. A majority of the resource is in unmined areas, with only the Las Chispas and William Tell veins being partially mined out and voids (stopes) being accounted for in the resource estimation. Since underground work continues in the Las Chispas Vein, details on revised pillar resources will not be complete until the next updated resource. Details of the drill assays, surface and underground sampling results can be found in various press releases from March 2, 2016 to September 13, 2018 and available on the Company's website. The resource remains open in several directions depending on which vein is considered. A Technical Report prepared in accordance with National Instrument 43-101 - Standards of Disclosure for Mineral Projects ("NI 43-101") will be filed on SEDAR at www.sedar.com within 45 days.

The Las Chispas resource estimate is based on the following key assumptions. A specific gravity of 2.55 was used based on test work. Veins were modelled to capture mineralization grade of 150 gpt AgEq or greater. For the veins in the Babicanora Area (approximately 80% of the updated resource), a minimum of 1.5 metres true width (a range of 1.5 to 6.0 metres) from drill hole intercepts was used to create vein shapes for modeling. For the Las Chispas Area, the true widths are variable (1 to 5 metres) for creating vein shapes for modeling as presented and estimated in the February 2018 maiden resource. Grade capping (top cut) of silver and gold grades are at 97.4 to 99.9 percentile depending on the vein. Specifically, by applying a 98 percentile top cut to the Babicanora Vein, approximately 7.5 million AgEq ounces (14%) were deducted from the total ounces estimated for the vein. Raw data was composited to 1.0 metres. A 2 metre by 2 metre by 2 metre block size was used based on geological constraints and potential future mining method. Variography, ordinary kriging and inverse distance squared (ID2) were used to create both silver and gold block models. A comparative review of ordinary kriging verses ID2 was completed, with total resource ounces nearly the same and ID2 conforming better to geologic constraints. Therefore, ID2 was used on all revised resources until infill drilling data is available to complete more representative variography. Block models were classified into Inferred Resources according to appropriate criteria based on geologic constraints, sample sets, and search radii. Details of these criteria will be presented in the Technical Report to be filed on SEDAR.

The Las Chispas resource estimate is focused on an estimated 5.5 kilometres of approximately 20 known kilometres of cumulative vein strike length in the district. As planned, the Company will continue the Phase III drilling up to Q1, 2019, which will focus on expansion and infill drill holes. Drilling priorities over the next six months are: (1) potential for Babicanora Norte Vein high-grade expansion, (2) potential for Granaditas Vein high-grade expansion, (3) further definition drilling on the Ranch veins, (4) further definition drilling for unnamed veins between the Babicanora Main and Babicanora Norte veins, (5) additional definition drilling on Babicanora Sur Vein, (6) Area 51 zone infill drilling for resource re-categorization, (7) initial infill drilling on several other high-grade veins, and (8) initial drilling on several other identified vein (new targets) on the Las Chispas Property. The Company intends to provide another updated resource estimate, with resource re-categorization, and deliver a PEA in Q1, 2019. There is no certainty that these Inferred Mineral Resources will be converted to the Measured and Indicated categories through further drilling.

Qualified Assurance Program and Quality Control Measures ("QA/QC")

SilverCrest has implemented QA/QC protocols including the insertion of duplicate, blank and standard samples in all drill holes and underground sampling. The samples were submitted directly to the ALS Chemex in Hermosillo, Mexico, and North Vancouver, BC, Canada, for preparation and analysis. SilverCrest's qualified person visited the Property numerous times, between February and September 2018. Duplicate and triplicate core sampling was completed with verified selective grades being reported to have a moderate to high nugget effect. SilverCrest's qualified person believes that all QA/QC work completed from February 2018 to September 2018 has been done to adequate standards. QA/QC work on the previous resource estimation announced in February 2018 was completed by P. James Barr, P.Geo. of Tetra Tech Inc. as an independent qualified person, with work completed to adequate standards.

Qualified Person

The Mineral Resources for the Las Chispas Property disclosed in this news release have been estimated by N. Eric Fier, CPG, P.Eng, and CEO of SilverCrest. Mr. Fier is a Qualified Person under NI 43-101 but not independent of the Company. Tetra Tech Inc. assisted with data statistical analysis, variography, and QA/QC review under the direction of P. James F. Barr, P. Geo., Senior Geologist and Team Lead - Geology for Tetra Tech and is independent of SilverCrest. Mr. Barr is a Qualified Person under NI 43-101. The Mineral Resources have been classified in accordance with CIM Definition Standards for Mineral Resources and Mineral Reserves. Mr. Fier has read and approved the contents of this press release as it pertains to the disclosed mineral resource estimate.

ABOUT SILVERCREST METALS INC.

SilverCrest is a Canadian precious metals exploration company headquartered in Vancouver, BC, that is focused on new discoveries, value-added acquisitions, and targeting production in Mexico's historic precious metal districts. The Company's current focus is on the high-grade, historic Las Chispas mining district in Sonora, Mexico. SilverCrest is the first company to successfully drill-test the historic Las Chispas Project resulting in numerous discoveries. The Company is led by a proven management team in all aspects of the precious metal mining sector, including taking projects through discovery, finance, on time and on budget construction, and production.

FORWARD-LOOKING STATEMENTS

This news release contains "forward-looking statements" within the meaning of Canadian securities legislation. These include, without limitation, statements with respect to: the strategic plans, timing and expectations for the Company's exploration, rehabilitation and drilling programs of the Las Chispas Property, including preparation of an updated mineral resource estimate and preliminary economic assessment; information with respect to high grade areas and size of veins projected from underground sampling results and drilling results; the accessibility of future mining at the Las Chispas Property; and the filing of a NI 43-101 technical report within 45 days. Such forward‑looking statements or information are based on a number of assumptions, which may prove to be incorrect. Assumptions have been made regarding, among other things: the conditions in general economic and financial markets; availability of skilled labour; timing and amount of expenditures related to rehabilitation and drilling programs; and effects of regulation by governmental agencies. The actual results could differ materially from those anticipated in these forward-looking statements as a result of risk factors including: the timing and content of work programs; results of exploration activities; the interpretation of drilling results and other geological data; receipt, maintenance and security of permits and mineral property titles; environmental and other regulatory risks; project cost overruns or unanticipated costs and expenses; and general market and industry conditions. Forward-looking statements are based on the expectations and opinions of the Company's management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statements were made. The Company undertakes no obligation to update or revise any forward-looking statements included in this news release if these beliefs, estimates and opinions or other circumstances should change, except as otherwise required by applicable law.

N. Eric Fier, CPG, P.Eng
Chief Executive Officer
SilverCrest Metals Inc.

For Further Information:

Contact: Fred Cooper, Investor Relations
Telephone: +1 (604) 694-1730
Fax: +1 (604) 357-1313
Toll Free: 1-866-691-1730 (Canada & USA)
Email: info@silvercrestmetals.com
Website: www.silvercrestmetals.com
570 Granville Street, Suite 501
Vancouver, British Columbia V6C 3P1

Neither TSX Venture Exchange nor its Regulation Services Provider (as defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SilverCrest Metals Inc. (TSXV: SIL.V; NYSE: SILV) is a featured company on Investorideas.com

Visit profile page

Get News Alerts on SilverCrest Metals Inc.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: Investorideas.com is compensated by SilverCrest Metals Inc for annual news publishing effective January 2017.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

About Investorideas.com

About Investorideas.com - Big Investing Ideas Investorideas.com is a platform for investing ideas. We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.

Disclaimer

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: For disclosure purposes SinglePoint Inc. (OTCQB: SING) is a paid news, PR and social media client on Investorideas.com

https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Disclaimer/ disclosure

Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.aspInvestorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Investorideas.com Social Media Disclaimer :

Investorideas.com supports the use of social media however content posted through these channels (Facebook, Twitter, LinkedIn, etc) is not to be taken as an endorsement of the information as we are not always able to ensure its original accuracy. Information provided on social media sites is not deemed to be a binding representation, agreement or endorsement on the part of the company. Please do your due diligence and always check facts in online communication channels. If any questions arise in this regard, feel free to contact us .

Gold Stocks and Mining Stocks News, Investing and Trading Ideas

Friday, October 26, 2018

Investorideas.com - Investor Ideas Adds New #Nasdaq IPOs in #Biotech (Nasdaq: $ALLO, $EQ, $GH, $KOD, $PRNB, $YMAB) & Newly Listed #CSE Stocks

Investor Ideas Adds New #Nasdaq IPOs in #Biotech (Nasdaq: $ALLO, $EQ, $GH, $KOD, $PRNB, $YMAB) & Newly Listed #CSE Stocks

CSE-Listed Stocks in #Mining, #Energy and #Nanotech (CSE: $CRES, $DLRY, $KAL, $SENS, $SONA)

Friday, October 12, 2018

Investorideas.com - Investor Ideas adds Nasdaq #Biotech #IPOs and CSE #Mining IPO Stocks to Directories (NASDAQ: $ADIL), (NASDAQ: $ALLK) (NASDAQ: $AQST), (CSE: $ZX.C)

Investor Ideas adds Nasdaq #Biotech #IPOs and CSE #Mining IPO Stocks to Directories (NASDAQ: $ADIL), (NASDAQ: $ALLK) (NASDAQ: $AQST), (CSE: $ZX.C)

Friday, September 21, 2018

Investorideas.com - Investor Ideas add new #Solar, #Cleantech, #Mining, #Blockchain, Tech, Water and Sports #Stocks to Global Directories

Investor Ideas add new #Solar, #Cleantech, #Mining, #Blockchain, Tech, Water and Sports #Stocks to Global Directories

Cleantech and Climate Change Podcast - Paul Hessburg, Research Landscape Ecologist talks about Recent Megafires and Solutions to Manage and Prevent Them

Wednesday, September 19, 2018

Investorideas.com Newswire - #Mining Stock News: #SilverCrest (TSXV: $SIL.V; NYSE: $SILV) Expands Las Chispas Inferred Resource 4.3 Million Tonnes at 3.68 gpt Au and 347 gpt Ag, or 623 gpt AgEq for 87 Million Oz AgEq; Includes 1.6 Million Tonnes at 1,091 gpt AgEq for 56 Million Oz AgEq

#Mining Stock News: #SilverCrest (TSXV: $SIL.V; NYSE: $SILV) Expands Las Chispas Inferred Resource 4.3 Million Tonnes at 3.68 gpt Au and 347 gpt Ag, or 623 gpt AgEq for 87 Million Oz AgEq; Includes 1.6 Million Tonnes at 1,091 gpt AgEq for 56 Million Oz AgEq

SilverCrest Metals Inc. (TSXV: SIL.V; NYSE: SILV) is a featured company on Investorideas.com

Mining stocks news alerts

Blog Archive

Links

Disclaimer/ disclosure